HOME >> MEDICINE >> NEWS
Columbia neurobiology fellow wins major career award from 2002 Burroughs Wellcome funding program

Kristin Scott, Ph.D., a postdoctoral fellow and research scientist in the Center for Neurobiology and Behavior at Columbia University Health Sciences, has been named a 2002 Burroughs Wellcome Fund career awardee in the biomedical sciences. The Burroughs Wellcome Fund Career Awards Program was established in 1995 to foster the development of promising biomedical researchers early in their careers and to help them make the transition from postdoctoral researcher to full-fledged independent investigator. Dr. Scott, who will receive a $500,000 grant from the Burroughs Wellcome Fund (BWF) to study taste representation in the brains of Drosophila (a type of fruit fly commonly used in biomedical research), is one of just 17 investigators across the United States named to this year's roster of winners.

A 1989 graduate of the University of Chicago with a bachelor's degree in biology, Dr. Scott subsequently pursued doctoral studies in neurobiology at the University of California at San Diego, where she studied phototransduction (the conversion of light into sensory stimuli) in Drosophila under the tutelage of Dr. Charles Zuker. Upon receiving her Ph.D. in 1998, Dr. Scott joined Columbia as a postdoctoral researcher in the laboratory of University Professor Richard Axel, M.D.-where today she investigates the gustatory system (mechanisms of taste) in Drosophila-at the Center for Neurobiology and Behavior. Dr. Scott is the recipient of a 1999 Life Sciences Research Fellowship at Columbia and has published articles about her research in a number of scholarly journals and publications, including Cell, the Proceedings of the National Academy of Sciences, and Nature.

"I am thrilled that Burroughs Wellcome has chosen to honor and perpetuate my work through the career awards program," said Dr. Scott. "Their long-term support will enable me to pursue my research systematically and comprehensively across two different stages of my career and to unravel the mystery of e
'"/>

Contact: Leslie Boen
lsb2001@columbia.edu
Columbia University Medical Center
29-Jul-2002


Page: 1 2

Related medicine news :

1. Columbia researchers receive $3 million to combat genetic killer of infants & toddlers
2. Columbia study shows widely used artery clearing device does not help patients during heart attack
3. Columbia study finds hemophilia therapy dramatically improves outcomes for bleeding stroke
4. First US kidney cancer vaccine trial underway at Columbia
5. RelayHealth selected by Columbia University to link doctors and patients online
6. Harlem Hospital Center, Columbia affiliate, recognized for efforts to fight glaucoma
7. Research by scientists affiliated with the Earth Institute at Columbia University
8. Columbia Univ. Medical Center wins highly competitive stroke grant from NIH
9. Brain Science Institute at Columbia University established by Kavli Foundation gift
10. Earth Institute at Columbia University hosts State of the Planet 2004
11. The Gerontological Society of America confers 2003 Lawton Award to Columbia Universitys Gurland

Post Your Comments:
(Date:8/28/2014)... 2014 Kirklyn Smith, an office manager for ... a new world’s record by walking 5,000 miles in a ... constantly amazed by the thousands of individual stories of TrekDesk ... to stand out more than the others. , Kirklyn has ... count which tallies a range of 54,823 steps (presumably on ...
(Date:8/28/2014)... (HealthDay News) -- Lack of sleep not only puts teens ... increased risk for obesity, researchers warn. The study authors ... were aged 16 and 21. Nearly one-fifth of them got ... were age 16, and this group was 20 percent more ... got more than eight hours of sleep per night at ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 NJ ... Institute of North Jersey. , NJ Top Doc, ... is now a certified medical examiner for the ... certified by the department to perform all drug ... training in diagnosing and treating musculoskeletal disorders including ...
(Date:8/28/2014)... In 2012, The Ben & Catherine Ivy Foundation ... brain cancer research projects at the Translational Genomics ... officially received the final regulatory approval from University ... for the trial can begin. , In the ... Trial," TGen and its clinical partners will lead ...
(Date:8/28/2014)... August 28, 2014 As Mirena IUD ... around the U.S., Bernstein Liebhard LLP notes that a ... like Mirena as ideal birth control for teenage girls. ... authors of the study point out that IUDs are ... other methods favored by this patient population. Their study, ...
Breaking Medicine News(10 mins):Health News:There are many reasons why Americans' exercise levels have declined - Meet an executive that refuses to sit still with his TrekDesk Treadmill Desk even in a sedentary job 2Health News:Less Sleep in Teen Years Tied to More Pounds at 21 2Health News:NJ Top Docs Presents Dr. Christophe Oliveira of Rehabilitation Instiute of North Jersey 2Health News:NJ Top Docs Presents Dr. Christophe Oliveira of Rehabilitation Instiute of North Jersey 3Health News:TGen receives approval for patient enrollment in brain cancer clinical trial 2Health News:Mirena IUD Lawsuit News: Bernstein Liebhard LLP Notes New Study Touting IUDs as Ideal Birth Control for Teenage Girls 2Health News:Mirena IUD Lawsuit News: Bernstein Liebhard LLP Notes New Study Touting IUDs as Ideal Birth Control for Teenage Girls 3Health News:Mirena IUD Lawsuit News: Bernstein Liebhard LLP Notes New Study Touting IUDs as Ideal Birth Control for Teenage Girls 4
(Date:8/28/2014)... Aug. 28, 2014  In recognition of the increased ... from the flu, pneumonia, shingles and other illnesses, ... declared September to be Senior Vaccination Month. Because ... is important that adults ages 65 years and ... CVS pharmacists and MinuteClinic nurse practitioners and physician ...
(Date:8/28/2014)... , Aug. 28, 2014 /PRNewswire/ ... market research report is available in ... Therapeutics in Asia-Pacific Markets to 2020 ... Unmet Need in Newly Diagnosed and ... http://www.reportlinker.com/p02343492/Glioblastoma-Multiforme-Therapeutics-in-Asia-Pacific-Markets-to-2020---Novel-Therapeutic-Approaches-Target-High-Unmet-Need-in-Newly-Diagnosed-and-Recurrent-GBM.html Glioblastoma ...
(Date:8/28/2014)... , Aug. 28, 2014 Telik, Inc. ... company that merged with MabVax Therapeutics, Inc. on ... significant progress related to the development of its ... was recovered using the Company,s internally developed antibody ... potential for multiple antibody based therapeutic and diagnostic ...
Breaking Medicine Technology:September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 2September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 3September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 4Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 2Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 3Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 4Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 5Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 6Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 7Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 8Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 9Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 2Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 3Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 4
Cached News: